The United States has the most number of coronavirus cases in the world. But rather than viewing the more than 1.5 million confirmed cases negatively, President Donald Trump says that it is just a reflection of his administration's successful testing.
“I view it as a badge of honor, really, it’s a badge of honor,” Donald Trump told reporters on Tuesday, according to Bloomberg. “It’s a great tribute to the testing and all of the work that a lot of professionals have done.”
Based on data from the Worldometers site, there are more than 1.5 million confirmed COVID-19 infections in the U.S. The country also has the highest number of fatalities with over 93 thousand deaths due to the pathogen.
The U.S. also posted the highest number of COVID-19 tests done with almost 13 million Americans already tested for the virus. The country with the second-highest number of tests is Russia with over 7.5 million tests done on its citizens.
Trump explained that it is only natural for the U.S. to have the highest number of confirmed coronavirus infections since it did the most number of tests. “If you’re testing 14 million people, you’re going to find many more cases,” the POTUS said.
He also added that viewed in this light, it’s not necessarily a bad thing to have the most number of cases. “Many of these people aren’t very sick but they still go down as a case, so, actually, the number of cases -- and we’re also a much bigger country than most,” Trump added. “So when we have a lot of cases, I don’t look at that as a bad thing, I look at that as, in a certain respect, as being a good thing because it means our testing is much better.”
But according to Bloomberg, the level of coronavirus testing done in the U.S. is not extraordinary. The nation is still behind Italy, Germany, and the U.K. in terms of the number of tests per 1,000 people. The publication also noted that the country is still facing testing shortages due to delays in the development and manufacturing of testing kits.


Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Taiwan Opposition Criticizes Plan to Block Chinese App Rednote Over Security Concerns
UN General Assembly Demands Russia Return Ukrainian Children Amid Ongoing Conflict
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
U.S.-Russia Talks Leave Ukraine Peace Efforts Uncertain
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Australia Progresses AUKUS Review as U.S. Affirms Strong Support
Pentagon Probe Finds Hegseth’s Use of Signal Risked Exposing Sensitive Yemen Strike Details 



